Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?

Overview

Journal Curr Heart Fail Rep

Publisher Current Science

Date 2020 Sep 2

PMID 32870447

Citations 5

Authors

Barbro Kjellstrom

Anthony Lindholm

Ellen Ostenfeld

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Pulmonary arterial hypertension (PAH) is a progressive disease with high mortality. A greater understanding of the physiology and function of the cardiovascular system in PAH will help improve survival. This review covers the latest advances within cardiovascular magnetic resonance imaging (CMR) regarding diagnosis, evaluation of treatment, and prognostication of patients with PAH.

Recent Findings: New CMR measures that have been proven relevant in PAH include measures of ventricular and atrial volumes and function, tissue characterization, pulmonary artery velocities, and arterio-ventricular coupling. CMR markers carry prognostic information relevant for clinical care such as treatment response and thereby can affect survival. Future research should investigate if CMR, as a non-invasive method, can improve existing measures or even provide new and better measures in the diagnosis, evaluation of treatment, and determination of prognosis of PAH.

Citing Articles

Cardiovascular magnetic resonance in patients with mitral valve prolapse.

Figliozzi S, Di Maio S, Georgiopoulos G, Vandenberk B, Chiribiri A, Francone M J Cardiovasc Magn Reson. 2024; 27(1):101137.

PMID: 39725235 PMC: 11786644. DOI: 10.1016/j.jocmr.2024.101137.

Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension.

Bandorski D, Heibel S, Holtgen R, Bogossian H, Ghofrani H, Zarse M Front Cardiovasc Med. 2023; 10:1084051.

PMID: 37139131 PMC: 10150006. DOI: 10.3389/fcvm.2023.1084051.

Novel Hybrid Treatment for Pulmonary Arterial Hypertension with or without Eisenmenger Syndrome: Double Lung Transplantation with Simultaneous Endovascular or Classic Surgical Closure of the Patent Ductus Arteriosus (PDA).

Stacel T, Sybila P, Medrala A, Ochman M, Latos M, Zawadzki F J Cardiovasc Dev Dis. 2022; 9(12).

PMID: 36547454 PMC: 9783473. DOI: 10.3390/jcdd9120457.

Data-driven computational models of ventricular-arterial hemodynamics in pediatric pulmonary arterial hypertension.

Tossas-Betancourt C, Li N, Shavik S, Afton K, Beckman B, Whiteside W Front Physiol. 2022; 13:958734.

PMID: 36160862 PMC: 9490558. DOI: 10.3389/fphys.2022.958734.

Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.

Wu S, Wu Y Acta Cardiol Sin. 2022; 38(2):113-123.

PMID: 35273432 PMC: 8888324. DOI: 10.6515/ACS.202203_38(2).20211005A.

References

Moon J, Messroghli D, Kellman P, Piechnik S, Robson M, Ugander M . Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013; 15:92. PMC: 3854458. DOI: 10.1186/1532-429X-15-92. View

Ferreira V, Piechnik S, DallArmellina E, Karamitsos T, Francis J, Ntusi N . T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013; 6(10):1048-1058. DOI: 10.1016/j.jcmg.2013.03.008. View

Marcus J, Mauritz G, Kind T, Vonk-Noordegraaf A . Interventricular mechanical dyssynchrony in pulmonary arterial hypertension: early or delayed strain in the right ventricular free wall?. Am J Cardiol. 2009; 103(6):894-5. DOI: 10.1016/j.amjcard.2009.01.002. View

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

Grapsa J, Gibbs J, Zimbarra Cabrita I, Watson G, Pavlopoulos H, Dawson D . The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging. 2012; 13(8):666-72. DOI: 10.1093/ehjci/jes003. View

Boucly A, Weatherald J, Savale L, Jais X, Cottin V, Prevot G . Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017; 50(2). DOI: 10.1183/13993003.00889-2017. View

Brewis M, Bellofiore A, Vanderpool R, Chesler N, Johnson M, Naeije R . Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. Int J Cardiol. 2016; 218:206-211. PMC: 5001160. DOI: 10.1016/j.ijcard.2016.05.015. View

Zou H, Leng S, Xi C, Zhao X, Koh A, Gao F . Three-dimensional biventricular strains in pulmonary arterial hypertension patients using hyperelastic warping. Comput Methods Programs Biomed. 2020; 189:105345. PMC: 7198336. DOI: 10.1016/j.cmpb.2020.105345. View

Leng S, Dong Y, Wu Y, Zhao X, Ruan W, Zhang G . Impaired Cardiovascular Magnetic Resonance-Derived Rapid Semiautomated Right Atrial Longitudinal Strain Is Associated With Decompensated Hemodynamics in Pulmonary Arterial Hypertension. Circ Cardiovasc Imaging. 2019; 12(5):e008582. DOI: 10.1161/CIRCIMAGING.118.008582. View

10.

Siqueira M, Pozo E, Fernandes V, Sengupta P, Modesto K, Gupta S . Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking. J Cardiovasc Magn Reson. 2016; 18(1):39. PMC: 4910232. DOI: 10.1186/s12968-016-0258-x. View

11.

Swift A, Rajaram S, Capener D, Elliot C, Condliffe R, Wild J . LGE patterns in pulmonary hypertension do not impact overall mortality. JACC Cardiovasc Imaging. 2014; 7(12):1209-17. DOI: 10.1016/j.jcmg.2014.08.014. View

12.

Lewis R, Johns C, Cogliano M, Capener D, Tubman E, Elliot C . Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2019; 201(4):458-468. PMC: 7049935. DOI: 10.1164/rccm.201909-1771OC. View

13.

Marston N, Auger W, Madani M, Kimura B, Strachan G, Raisinghani A . Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Cardiovasc Ultrasound. 2014; 12:32. PMC: 4131478. DOI: 10.1186/1476-7120-12-32. View

14.

Nitsche C, Kammerlander A, Binder C, Duca F, Aschauer S, Koschutnik M . Native T1 time of right ventricular insertion points by cardiac magnetic resonance: relation with invasive haemodynamics and outcome in heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging. 2019; 21(6):683-691. DOI: 10.1093/ehjci/jez221. View

15.

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Correction to: Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for.... J Cardiovasc Magn Reson. 2018; 20(1):9. PMC: 5804075. DOI: 10.1186/s12968-017-0408-9. View

16.

Bane O, Shah S, Cuttica M, Collins J, Selvaraj S, Chatterjee N . A non-invasive assessment of cardiopulmonary hemodynamics with MRI in pulmonary hypertension. Magn Reson Imaging. 2015; 33(10):1224-1235. PMC: 4658324. DOI: 10.1016/j.mri.2015.08.005. View

17.

Klima U, Lee M, Guerrero J, Laraia P, Levine R, Vlahakes G . Determinants of maximal right ventricular function: role of septal shift. J Thorac Cardiovasc Surg. 2002; 123(1):72-80. DOI: 10.1067/mtc.2002.118683. View

18.

Lindholm A, Hesselstrand R, Radegran G, Arheden H, Ostenfeld E . Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se. Clin Physiol Funct Imaging. 2019; 39(3):215-225. PMC: 6850088. DOI: 10.1111/cpf.12561. View

19.

Agoston-Coldea L, Lupu S, Mocan T . Pulmonary Artery Stiffness by Cardiac Magnetic Resonance Imaging Predicts Major Adverse Cardiovascular Events in patients with Chronic Obstructive Pulmonary Disease. Sci Rep. 2018; 8(1):14447. PMC: 6160404. DOI: 10.1038/s41598-018-32784-6. View

20.

Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, ODonnell T . Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol. 2007; 100(4):731-5. DOI: 10.1016/j.amjcard.2007.03.094. View